MedTrace Logo

Study of Depression, Peptides, and Steroids in Cushing's Syndrome

NCT00004334 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 8

Last updated 2005-06-24

No results posted yet for this study

Summary

OBJECTIVES: I. Study the relationship between dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis and disorders of mood, vegetative function, and cognition in patients with Cushing's disease.

II. Identify subgroups of patients with Cushing's disease who differ in the presence and severity of the depressive syndrome, and uncover HPA axis dysregulation differences among them using corticotropin-releasing hormone, metyrapone, and dexamethasone challenge testing.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Monica N. Starkman · University of Michigan

Eligibility

Min Age
20 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
1994-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00004334 on ClinicalTrials.gov